(Erolinyl)-N,N-diethylurea derivatives, and their preparation and use
US4379790A · kind A · utility
7Cited by
4References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 6, 1982 |
| Grant date | Apr 12, 1983 |
| Priority date | — |
| Expiry date | Jan 6, 2002 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of the formula ##STR1## or a pharmaceutically acceptable salt thereof, wherein R.sub.1 is alkyl of 2-6 carbon atoms, ##STR2## n is 1, or 2, m is 0 or 1, PA1 R.sub.2 is alkyl of 1-6 carbon atoms, ##STR3## is a CC single bond or a CC double bond, and the 8-positioned urea residue can be in the .alpha.- or .beta.-position, have valuable pharmacological properties, e.g., lactation inhibition and anti-Parkinsonism.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.